323
Participants
Start Date
October 20, 2009
Primary Completion Date
March 21, 2011
Study Completion Date
March 21, 2011
GSK2340274A
Two intramuscular injections
GSK2340273A
Two intramuscular injections
GSK Investigational Site, Kingsport
GSK Investigational Site, Bardstown
GSK Investigational Site, Cleveland
GSK Investigational Site, Saint Paul
GSK Investigational Site, Arkansas City
GSK Investigational Site, Wichita
GSK Investigational Site, Omaha
GSK Investigational Site, Metairie
GSK Investigational Site, Conway
GSK Investigational Site, Little Rock
GSK Investigational Site, Fort Worth
GSK Investigational Site, San Angelo
GSK Investigational Site, Austin
GSK Investigational Site, Orem
GSK Investigational Site, South Jordan
GSK Investigational Site, San Francisco
GSK Investigational Site, Sacramento
GSK Investigational Site, Coquitlam
GSK Investigational Site, Winnipeg
GSK Investigational Site, St. John's
GSK Investigational Site, Halifax
GSK Investigational Site, Brampton
GSK Investigational Site, Greater Sudbury
GSK Investigational Site, Hamilton
GSK Investigational Site, Newmarket
GSK Investigational Site, Toronto
GSK Investigational Site, Toronto
GSK Investigational Site, Montreal
GSK Investigational Site, Québec
GSK Investigational Site, Sherbrooke
Lead Sponsor
GlaxoSmithKline
INDUSTRY